KEI Comments on NIH Proposed Exclusive Patent License to St. Louis University for Treatment and Prevention of Neuropathic Pain With P2Y14 Antagonists

On December 3, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) regarding the “Prospective Grant of Exclusive Patent License: Treatment and Prevention of Neuropathic… Continue Reading